Tuesday - June 9, 2026
Whitehouse Cheers Landmark Pancreatic Cancer Drug
June 04, 2026
WASHINGTON, June 4 -- Sen. Sheldon Whitehouse, D-Rhode Island, issued the following news release:

* * *

Whitehouse Cheers Landmark Pancreatic Cancer Drug

*

Whitehouse's Recalcitrant Cancer Research Act supported foundational research behind the breakthrough

Washington, DC - Today, U.S. Senator Sheldon Whitehouse (D-RI) cheered the results of Revolution Medicines' clinical trial for its new pancreatic cancer drug daraxonr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products